Central terminals of nociceptors are targets for nicotine suppression of inflammation

Neuroscience

Volumn 123, Issue 3, 2004, Pages 777-784

  Miao, F J P ^a,b   Green, P G ^a,b   Benowitz, N ^c   Levine, J D ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Descending antinociceptive controls; Opioid; Plasma extravasation; adrenergic

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CAPSAICIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROTRANSMITTER; NICOTINE; OPIATE ANTAGONIST; PHENTOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; INFLAMMATION; MALE; MUSCLE SPINDLE AFFERENT NERVE; NERVE ENDING; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0346729793     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.10.027     Document Type: Article

References (70)

1. (2+) currents in rat sensory neurons. J Neurosci. 19:1999;8337-8348.
2. Benowitz N.L. The biology of nicotine dependence from the 1988 Surgeon General's Report to the present and into the future . Nicotine Tobacco Res. 1:(Suppl 2):1999;S159-163.
3. Bergman T.A., Johnson D.L., Boatright D.T., Smallwood K.G., Rando R.J. Occupational exposure of nonsmoking nightclub musicians to environmental tobacco smoke. Am Ind Hyg Assoc J. 57:1996;746-752.
4. Bhattacharya S.K., Saraswati M., Sen A.P. Effect of centrally administered enkephalins on carrageenin-induced paw oedema in rats. Res Exp Med (Berl). 192:1992;443-449.
5. Birder L.A., Perl E.R. Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation. J Physiol (Lond). 515:(Pt 2):1999;533-542.
6. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-394.
7. Carlton S.M. Peripheral excitatory amino acids. Curr Opin Pharmacol. 1:2001;52-56.
8. Carr J., Wilhelm D.L. The evaluation of increased vascular permeability in the skin of guinea pigs. Aust J Exp Biol Med Sci. 42:1964;511-522.
9. Coderre T.J., Basbaum A.I., Levine J.D. Neural control of vascular permeability interactions between primary afferents, mast cells, and sympathetic efferents . J Neurophysiol. 62:1989;48-58.
10. Coderre T.J., Chan A.K., Helms C., Basbaum A.I., Levine J.D. Increasing sympathetic nerve terminal-dependent plasma extravasation correlates with decreased arthritic joint injury in rats. Neuroscience. 40:1991;185-189.
11. Coudoré-Civiale M.-A., Courteix C., Eschalier A., Fialip J. Effect of tachykinin receptor antagonists in experimental neuropathic pain. Eur J Pharmacol. 361:1998;175-184.
12. Doubell T., Mannion R., Woolf C. The dorsal horn: state-dependent sensory processing, plasticity and the generation of pain. Wall P., Melzack R. Textbook of pain. 1999;165-181 Churchill Livingstone, London.
13. Eliakim R., Fan Q.X., Babyatsky M.W. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol. 14:2002;607-614.
14. Fleming W.W., Westfall D.P., De la Lande I.S., Jellett L.B. Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther. 181:1972;339-345.
15. Genzen JR, McGehee D S (2003) Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 100:6807-6812.
16. Genzen J.R., Van Cleve W., McGehee D.S. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol. 86:2001;1773-1782.
17. Gold M.S., Dastmalchi S., Levine J.D. Alpha 2-adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain. 69:1997;179-190.
18. Gunby P. Surgeon general emphasizes nicotine addiction in annual report on tobacco use, consequences. JAMA. 259:1988;2811.
19. Hargreaves K.M., Roszkowski M.T., Swift J.Q. Bradykinin and inflammatory pain. Agents Actions Suppl. 41:1993;65-73.
20. Hernandez Avila M., Liang M.H., Willett W.C., Stampfer M.J., Colditz G.A., Rosner B., Roberts W.N., Hennekens C.H., Speizer F.E. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology. 1:1990;285-291.
21. Hutchinson D., Shepstone L., Moots R., Lear J.T., Lynch M.P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 60:2001;223-227.
22. Kaplan A.P., Joseph K., Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 109:2002;195-209.
23. Karlson E.W., Lee I.M., Cook N.R., Manson J.E., Buring J.E., Hennekens C.H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 42:1999;910-917.
24. Keast J.R., Stephensen T.M. Glutamate and aspartate immunoreactivity in dorsal root ganglion cells supplying visceral and somatic targets and evidence for peripheral axonal transport. J Comp Neurol. 424:2000;577-587.
25. Khan I.M., Marsala M., Printz M.P., Taylor P., Yaksh T.L. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J Pharmacol Exp Ther. 278:1996;97-106.
26. Khan I.M., Taylor P., Yaksh T.L. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally. J Pharmacol Exp Ther. 270:1994;150-158.
27. Khan I.M., Taylor P., Yaksh T.L. Stimulatory pathways and sites of action of intrathecally administered nicotinic agents. J Pharmacol Exp Ther. 271:1994;1550-1557.
28. King A.P., Hall K.E., Macdonald R.L. Kappa- and mu-opioid inhibition of N-type calcium currents is attenuated by 4beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons. J Pharmacol Exp Ther. 289:1999;312-320.
29. Kirwan J.R. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol. 36:1997;225-228.
30. Kubo K., Kita T., Narushima I., Tanaka T., Nakatani T., Nakashima T. Nicotine-induced inflammatory decreasing effect on passive skin arthus reaction in paraventricular nucleus-lesioned Wistar rats. Pharmacol Toxicol. 92:2003;125-130.
31. Levine J.D., Dardick S.J., Roizen M.F., Helms C., Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci. 6:1986;3423-3429.
32. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature. 386:1997;721-724.
33. Masdottir B., Jonsson T., Manfredsdottir V., Vikingsson A., Brekkan A., Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford). 39:2000;1202-1205.
34. Matta S.G., Fu Y., Valentine J.D., Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology. 23:1998;103-113.
35. Miao F.J., Benowitz N.L., Heller P.H., Levine J.D. Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat. Br J Pharmacol. 120:1997;298-304.
36. Miao F.J., Benowitz N.L., Levine J.D. Endogenous opioids suppress activation of nociceptors by sub-nanomolar nicotine. Br J Pharmacol. 133:2001;23-28.
37. Miao F.J., Dallman M.F., Benowitz N.L., Basbaum A.I., Levine J.D. Adrenal medullary modulation of the inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine. J Pharmacol Exp Ther. 264:1993;839-844.
38. Miao F.J., Helms C., Benowitz N.L., Basbaum A.I., Heller P.H., Levine J.D. Chronically administered nicotine attenuates bradykinin-induced plasma extravasation and aggravates arthritis-induced joint injury in the rat. Neuroscience. 51:1992;649-655.
39. Miao F.J., Janig W., Dallman M.F., Benowitz N.L., Heller P.H., Basbaum A.I., Levine J.D. Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine. J Neurophysiol. 72:1994;1199-1207.
40. Miao F.J., Janig W., Green P.G., Levine J.D. Inhibition of bradykinin-induced plasma extravasation produced by noxious cutaneous and visceral stimuli and its modulation by vagal activity. J Neurophysiol. 78:1997;1285-1292.
41. Miao F.J., Janig W., Jasmin L., Levine J.D. Spino-bulbo-spinal pathway mediating vagal modulation of nociceptive-neuroendocrine control of inflammation in the rat. J Physiol. 532:2001;811-822.
42. Miao F.J., Janig W., Levine J.D. Vagal branches involved in inhibition of bradykinin-induced synovial plasma extravasation by intrathecal nicotine and noxious stimulation in the rat. J Physiol (Lond). 498:(Pt 2):1997;473-481.
43. Miao F.J., Janig W., Levine J.D. Nociceptive neuroendocrine negative feedback control of neurogenic inflammation activated by capsaicin in the rat paw role of the adrenal medulla . J Physiol (Lond). 527:(Pt 3):2000;601-610.
44. Miao F.J., Lee T.J. Effects of bilirubin on cerebral arterial tone in vitro. J Cereb Blood Flow Metab. 9:1989;666-674.
45. Miao F.J., Levine J.D. Neural and endocrine mechanisms mediating noxious stimulus-induced inhibition of bradykinin plasma extravasation in the rat. J Pharmacol Exp Ther. 291:1999;1028-1037.
46. Ninkovic M., Hunt S.P. Alpha-bungarotoxin binding sites on sensory neurones and their axonal transport in sensory afferents. Brain Res. 272:1983;57-69.
47. Nishiyama T., Gyermek L., Lee C., Kawasaki-Yatsugi S., Yamaguchi T. Synergistic analgesic effects of intrathecal midazolam and NMDA or AMPA receptor antagonists in rats. Can J Anaesth. 48:2001;288-294.
48. 3H]-glutamate release from cultured dorsal root ganglion neurons. Biochem Soc Trans. 26:1998;S108.
49. Roberts R.G., Stevenson J.E., Westerman R.A., Pennefather J. Nicotinic acetylcholine receptors on capsaicin-sensitive nerves. Neuroreport. 6:1995;1578-1582.
50. Robinson J.H., Pritchard W.S. The role of nicotine in tobacco use. Psychopharmacology (Berl). 108:1992;397-407.
51. Rogers D.T., Iwamoto E.T. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther. 267:1993;341-349.
52. Rueter L.E., Meyer M.D., Decker M.W. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain. Brain Res. 872:2000;93-101.
53. Rydh-Rinder M., Kerekes N., Svensson M., Hokfelt T. Glutamate release from adult primary sensory neurons in culture is modulated by growth factors. Regul Pept. 102:2001;69-79.
54. Saag K.G., Cerhan J.R., Kolluri S., Ohashi K., Hunninghake G.W., Schwartz D.A. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 56:1997;463-469.
55. Shi T.S., Winzer-Serhan U., Leslie F., Hokfelt T. Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia. Pain. 84:2000;319-330.
56. Sluka K.A., Willis W.D. Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor. Brain Res. 798:1998;281-286.
57. Swift J.Q., Garry M.G., Roszkowski M.T., Hargreaves K.M. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain. J Oral Maxillofac Surg. 51:1993;112-116.
58. Sykes A.P., Brampton C., Klee S., Chander C.L., Whelan C., Parsons M.E. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res. 49:2000;311-319.
59. Symmons D.P., Bankhead C.R., Harrison B.J., Brennan P., Barrett E.M., Scott D.G., Silman A.J. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis results from a primary care-based incident case-control study in Norfolk, England . Arthritis Rheum. 40:1997;1955-1961.
60. Theisen-Popp P., Muller-Peddinghaus R. Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents Actions. 42:1994;50-55.
61. Trout D., Decker J., Mueller C., Bernert J.T., Pirkle J. Exposure of casino employees to environmental tobacco smoke. J Occup Environ Med. 40:1998;270-276.
62. Tuomi T., Heliovaara M., Palosuo T., Aho K. Smoking, lung function, and rheumatoid factors. Ann Rheum Dis. 49:1990;753-756.
63. Uhlig T., Hagen K.B., Kvien T.K. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol. 26:1999;47-54.
64. Vessey M.P., Villard-Mackintosh L., Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception. 35:1987;457-464.
65. Wang H., Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J Comp Neurol. 429:2001;590-600.
66. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 421:2003;384-388.
67. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol. 27:2000;630-637.
68. Wooltorton J.R., Pidoplichko V.I., Broide R.S., Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci. 23:2003;3176-3185.
69. Yaksh T.C., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
70. Zhuo M. NMDA receptor-dependent long term hyperalgesia after tail amputation in mice. Eur J Pharmacol. 349:1998;211-220.